PMV Pharmaceuticals
PMVP
PMVP
70 hedge funds and large institutions have $58.8M invested in PMV Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 31 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 74 → 70 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
52% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 31
Holders
70
Holding in Top 10
1
Calls
$115K
Puts
$19K
Top Buyers
| 1 | +$2.68M | |
| 2 | +$809K | |
| 3 | +$540K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$146K |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$103K |
Top Sellers
| 1 | -$1.43M | |
| 2 | -$820K | |
| 3 | -$657K | |
| 4 |
Goldman Sachs
New York
|
-$587K |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$302K |